Sign in
Taking people in United StatesNo phase

Tests a glucose sensor app and coaching for pregnant adults with type 2 diabetes

Tests a glucose sensor app with coaching in pregnant adults with type 2 diabetes.

Key facts

Who runs it
Ohio State University
Where
Columbus, United StatesSee the site
Trial code
Registry title
Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching
Status
Recruiting
People taking part
124 people, planned
Started
11 Jul 2024
Expected to end
Mar 2029
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • DEXCOM G7 PRO Continuous Glucose Monitor
  • Patient mHealth app linked to a provider dashboard
  • Care team coaching for medical and social needs (HUB)
  • Provider dashboard
Record updated
29 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for pregnant women aged 18 or older who have type 2 diabetes from before pregnancy and a high A1c at enrolment. It tests an app with a glucose sensor and coaching against standard care.

Age
18 years or older
Sex
Female only (pregnant individuals)
Disease stage
Up to 20 weeks of pregnancy (less than 20+6 weeks). Type 2 diabetes diagnosed before pregnancy, with A1c of 6.5% (48 mmol/mol) or higher at enrolment.
Biomarker or test result
A1c of 6.5% (48 mmol/mol) or higher at the time of enrolment

Main reasons for not taking part

  • Not on Medicaid insurance
  • Does not speak English or Spanish
  • No smartphone with internet access
  • Not able to complete the study requirements
  • Does not consent to all study activities

This trial only enrols pregnant participants. The registry sentence this rests on: pregnant individuals age ≥18 years;

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • pregnant individuals age ≥18 years
  • ≤20 weeks of gestation (specifically, <20+6 weeks)
  • diagnosis of pregestational T2D and A1c ≥6.5% at the time of study enrollment
  • Medicaid insurance
  • English or Spanish speaking
  • cognitively able to complete the study requirements
  • consent to all study activities
  • accessible for participation in study activities
  • use a smartphone with internet access; Participants must also consent to the study team abstracting information from their electronic health records (EHRs), using CGM for glucose monitoring if randomized to the intervention group, tracking the participants' clinic, hospital, and emergency room visits during the study period, as well as tracking the number of times the participants use the ACHIEVE mobile health (mHealth) application (app), including what activities are used in the mobile application (e.g., recording blood glucose, scheduling appointments, messaging their healthcare providers, accessing educational resources)

Where in United States

  • The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal MedicineColumbus, United StatesContact: Kartik Venkatesh, MD, PhDTaking people

About the trial

What the trial wants to find out

The ACHIEVE RCT will measure the effect of the intervention (mHealth app with CGM, provider dashboard, and care team coaching) compared to current standard care (prenatal visits, self-monitored blood glucose, and certified diabetes care and education specialist) on achieving glycemic control (hemoglobin A1c <6.5% in the third trimester). We hypothesize a 25% absolute increase in the proportion of participants in the intervention group who will meet the target hemoglobin A1c <6.5% in the third trimester compared to the standard care group

The 2 groups in the trial

  • ACHIEVE InterventionExisting treatment, for comparison

    The intervention includes a multi-component, including a mobile health (mHealth) application (app), provider dashboard, DEXCOM continuous glucose monitoring (CGM), and care team coaching for medical and social needs. The intervention group will also receive standard of care as described below.

    Treatment: DEXCOM G7 PRO Continuous Glucose Monitor, Patient mHealth app linked to a provider dashboard, Care team coaching for medical and social needs (HUB), and Provider dashboard

  • Standard of careNo study treatment, for comparison

    Standard of care includes prenatal visits, self-monitored blood glucose, and certified diabetes care and education specialist support.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
ACHIEVE: Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching
Plain-language title
Tests a glucose sensor app and coaching for pregnant adults with type 2 diabetesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Publications
Record updated
29 June 2026